Search

Author/Creator te Boekhorst, Peter A.W.

1. Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 109/L to <100 × 109/L) at baseline: the final analysis of EXPAND. (September 2022)

Authors:
Guglielmelli, Paola; Kiladjian, Jean-Jacques; Vannucchi, Alessandro M.; Duan, Minghui; Meng, Haitao; Pan, Ling; He, Guangsheng; Verstovsek, Srdan; Boyer, Françoise; Barraco, Fiorenza; Niederwieser, Dietger; Pungolino, Ester; Liberati, Anna Marina; Harrison, Claire; Roussou, Pantelia; Wroclawska, ...
Journal:
Therapeutic advances in hematology
Issue:
Volume 13(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells. (June 2021)

Authors:
Mout, Lisanne; van Dessel, Lisanne F.; Kraan, Jaco; de Jong, Anouk C.; Neves, Rui P.L.; Erkens-Schulze, Sigrun; Beaufort, Corine M.; Sieuwerts, Anieta M.; van Riet, Job; Woo, Thomas L.C.; de Wit, Ronald; Sleijfer, Stefan; Hamberg, Paul; Sandberg, Yorick; te Boekhorst, Peter A.W.; van de Werken, H...
Journal:
European journal of cancer
Issue:
Volume 150(2021)
Page Start:
179
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Results of the prematurely terminated TEMPLE randomized controlled trial in patients with myelodysplastic syndrome: liberal versus restrictive red blood cell transfusion threshold. Issue 4 (4th April 2020)

Authors:
Gerard Jansen, A.J.; van den Bosch, Joan; te Boekhorst, Peter A.W.; Schipperus, Martin R.; Beckers, Erik AM
Journal:
Transfusion
Issue:
Volume 60:Issue 4(2020)
Page Start:
879
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗